Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Susan Ingram to Periaqueductal Gray

This is a "connection" page, showing publications Susan Ingram has written about Periaqueductal Gray.

 
Connection Strength
 
 
 
6.300
 
  1. Coutens B, Bouchet CA, Patti LC, McPherson KB, Boston BS, Jewett DC, Ingram SL. Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaqueductal gray. Mol Pharmacol. 2025 08; 107(8):100058.
    View in: PubMed
    Score: 0.891
  2. McPherson KB, Bouchet CA, Coutens B, Ingram SL. Persistent inflammation selectively activates opioid-sensitive phasic-firing neurons within the vlPAG. J Neurophysiol. 2023 05 01; 129(5):1237-1248.
    View in: PubMed
    Score: 0.767
  3. McPherson KB, Leff ER, Li MH, Meurice C, Tai S, Traynor JR, Ingram SL. Regulators of G-Protein Signaling (RGS) Proteins Promote Receptor Coupling to G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channels. J Neurosci. 2018 10 10; 38(41):8737-8744.
    View in: PubMed
    Score: 0.556
  4. Tonsfeldt KJ, Suchland KL, Beeson KA, Lowe JD, Li MH, Ingram SL. Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation. J Neurosci. 2016 Feb 03; 36(5):1669-81.
    View in: PubMed
    Score: 0.465
  5. Ingram SL. Association of mu-opioid and NMDA receptors in the periaqueductal gray: what does it mean for pain control? Neuropsychopharmacology. 2012 Jan; 37(2):315-6.
    View in: PubMed
    Score: 0.350
  6. Fyfe LW, Cleary DR, Macey TA, Morgan MM, Ingram SL. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther. 2010 Dec; 335(3):674-80.
    View in: PubMed
    Score: 0.319
  7. Morgan MM, Bobeck EN, Ingram SL. Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res. 2009 Oct 27; 1295:59-66.
    View in: PubMed
    Score: 0.296
  8. Meyer PJ, Morgan MM, Kozell LB, Ingram SL. Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl). 2009 Jun; 204(3):531-40.
    View in: PubMed
    Score: 0.287
  9. Ingram SL, Macey TA, Fossum EN, Morgan MM. Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology. 2008 Sep; 33(10):2494-504.
    View in: PubMed
    Score: 0.264
  10. Morgan MM, Fossum EN, Levine CS, Ingram SL. Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol Biochem Behav. 2006 Sep; 85(1):214-9.
    View in: PubMed
    Score: 0.243
  11. Morgan MM, Tierney BW, Ingram SL. Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res. 2005 Oct 19; 1059(2):173-8.
    View in: PubMed
    Score: 0.227
  12. Bagley EE, Ingram SL. Endogenous opioid peptides in the descending pain modulatory circuit. Neuropharmacology. 2020 08 15; 173:108131.
    View in: PubMed
    Score: 0.156
  13. Bouchet CA, Ingram SL. Cannabinoids in the descending pain modulatory circuit: Role in inflammation. Pharmacol Ther. 2020 05; 209:107495.
    View in: PubMed
    Score: 0.153
  14. Ingram SL. Cellular and molecular mechanisms of opioid action. Prog Brain Res. 2000; 129:483-92.
    View in: PubMed
    Score: 0.152
  15. Bobeck EN, Schoo SM, Ingram SL, Morgan MM. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats. J Pain. 2019 09; 20(9):1040-1047.
    View in: PubMed
    Score: 0.144
  16. Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ. Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci. 1998 Dec 15; 18(24):10269-76.
    View in: PubMed
    Score: 0.142
  17. Macey TA, Bobeck EN, Suchland KL, Morgan MM, Ingram SL. Change in functional selectivity of morphine with the development of antinociceptive tolerance. Br J Pharmacol. 2015 Jan; 172(2):549-61.
    View in: PubMed
    Score: 0.104
  18. Mehalick ML, Ingram SL, Aicher SA, Morgan MM. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat. J Pain. 2013 Dec; 14(12):1601-10.
    View in: PubMed
    Score: 0.099
  19. Suckow SK, Deichsel EL, Ingram SL, Morgan MM, Aicher SA. Columnar distribution of catecholaminergic neurons in the ventrolateral periaqueductal gray and their relationship to efferent pathways. Synapse. 2013 Feb; 67(2):94-108.
    View in: PubMed
    Score: 0.093
  20. Bobeck EN, Haseman RA, Hong D, Ingram SL, Morgan MM. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat. J Pain. 2012 Aug; 13(8):799-807.
    View in: PubMed
    Score: 0.091
  21. Macey TA, Bobeck EN, Hegarty DM, Aicher SA, Ingram SL, Morgan MM. Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat. J Pharmacol Exp Ther. 2009 Nov; 331(2):412-8.
    View in: PubMed
    Score: 0.074
  22. Morgan MM, Ashley MD, Ingram SL, Christie MJ. Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plast. 2009; 2009:516328.
    View in: PubMed
    Score: 0.072
  23. Fossum EN, Lisowski MJ, Macey TA, Ingram SL, Morgan MM. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res. 2008 Apr 14; 1204:53-8.
    View in: PubMed
    Score: 0.067
  24. Meyer PJ, Fossum EN, Ingram SL, Morgan MM. Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology. 2007 Jun; 52(8):1580-5.
    View in: PubMed
    Score: 0.063
  25. Ingram SL, Fossum EN, Morgan MM. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats. Neuropsychopharmacology. 2007 Mar; 32(3):600-6.
    View in: PubMed
    Score: 0.060
  26. Connor M, Bagley EE, Mitchell VA, Ingram SL, Christie MJ, Humphrey PP, Vaughan CW. Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro. Br J Pharmacol. 2004 Aug; 142(8):1273-80.
    View in: PubMed
    Score: 0.052
  27. Vaughan CW, Ingram SL, Connor MA, Christie MJ. How opioids inhibit GABA-mediated neurotransmission. Nature. 1997 Dec 11; 390(6660):611-4.
    View in: PubMed
    Score: 0.033
  28. Vaughan CW, Ingram SL, Christie MJ. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci. 1997 Feb 01; 17(3):996-1003.
    View in: PubMed
    Score: 0.031
  29. Bobeck EN, Ingram SL, Hermes SM, Aicher SA, Morgan MM. Ligand-biased activation of extracellular signal-regulated kinase 1/2 leads to differences in opioid induced antinociception and tolerance. Behav Brain Res. 2016 Feb 01; 298(Pt B):17-24.
    View in: PubMed
    Score: 0.028
  30. Macey TA, Ingram SL, Bobeck EN, Hegarty DM, Aicher SA, Arttamangkul S, Morgan MM. Opioid receptor internalization contributes to dermorphin-mediated antinociception. Neuroscience. 2010 Jun 30; 168(2):543-50.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)